MarketWatch

FDA Grants Authorisation for Minder(R), the First and Only Implantable Continuous EEG Monitor Approved in US

-- The Australian-developed Minder system is an implantable device for continuous monitoring of brain activity in patients with epilepsy, developed to address the shortcomings in current ...
Business Wire

Epiminder Announces Publication of Landmark Clinical Trial Confirming Safety and Efficacy of the Minder® System

First clinical trial published demonstrating safety and efficacy of a bilateral continuous EEG monitoring system Clinically relevant findings were identified in 88% of patients High-quality, durable ...
Nasdaq

Ceribell Receives FDA 510(k) Clearance for First-of-its-Kind Delirium Monitoring Solution

Novel technology paves the way for use of the company's industry-leading point-of-care electroencephalography (EEG) system to address long unmet need in delirium monitoring SUNNYVALE, Calif., Dec. 09, ...
TMCnet

Mentis Care Announces Research Collaboration with Emory University to Advance Channel-Agnostic AI for Seizure Detection and Prediction

A multi-year Sponsored Research Agreement with Emory's School of Medicine to build a transformer-based EEG foundation model ...
New Atlas

Single hair-like electrode outperforms traditional 21-lead EEG

Researchers have developed a 3D-printable electrode that looks like a single strand of human hair and measures brain activity more reliably than the current method used to diagnose things like ...
abc27

FDA Grants Authorisation for Minder®, the First and Only Implantable Continuous EEG Monitor Approved in US

MELBOURNE, Australia and DALLAS, April 22, 2025 /PRNewswire/ -- Epiminder, a pioneering medical device and information solutions company, today announced that it has been granted FDA authorisation via ...